Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (291-300 of 447) with videos related to

Pageof 45
Sort By:
Plos Medicine|December 7, 2016
Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
Plos Medicine|January 10, 2017
Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
JCO Precision Oncology|September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal AdenocarcinomaStephane Wenric, Chithra Sangli, John Guittar, et al.
Science Advances|September 27, 2024
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growthSandeep Artham, Patrick K Juras, Aditi Goyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Lindsay A Brown, Jeremy Hoog, Suet-Feung Chin, et al.
BMC Medical Genomics|November 3, 2011
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low featuresVilde D Haakensen, Ole Christian Lingjaerde, Torben Lüders, et al.
BMC Bioinformatics|January 30, 2020
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approachesArran K Turnbull, Cigdem Selli, Carlos Martinez-Perez, et al.
Pageof 45

Showing results (291-300 of 447) with videos related to

Sort By:
Pageof 45
Plos Medicine|December 7, 2016
Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
Plos Medicine|January 10, 2017
Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesKatherine A Hoadley, Marni B Siegel, Krishna L Kanchi, et al.
JCO Precision Oncology|September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal AdenocarcinomaStephane Wenric, Chithra Sangli, John Guittar, et al.
Science Advances|September 27, 2024
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growthSandeep Artham, Patrick K Juras, Aditi Goyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Cancer Research|April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancerRobert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Lindsay A Brown, Jeremy Hoog, Suet-Feung Chin, et al.
BMC Medical Genomics|November 3, 2011
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low featuresVilde D Haakensen, Ole Christian Lingjaerde, Torben Lüders, et al.
BMC Bioinformatics|January 30, 2020
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approachesArran K Turnbull, Cigdem Selli, Carlos Martinez-Perez, et al.
Pageof 45